Document |
Document Title |
WO/2016/142126A1 |
The invention relates to novel nitrogenous compounds pertaining to the family of tertiary polyether alkanolamines of general formula (I) wherein x is a whole number between 0 and 10, R1 is independently selected from an alkyl radical com...
|
WO/2016/140302A1 |
The present invention provides a polyimide precursor in which the quantity of radicals generated is relatively large. Through this polyimide precursor, reaction of a polymerizable compound is accelerated, the pretilt angle in liquid crys...
|
WO/2016/140232A1 |
The present invention pertains to a peptide synthesis reaction using a carrier which can reversibly repeat a dissolved state and an encapsulated state, wherein it is easy to solve the problem of amino acid active species which are presen...
|
WO/2016/140358A1 |
The purpose of the present invention is to provide a catalyst composite body which has an excellent reducing action. The above-described problem is able to be solved by a catalyst composite body according to the present invention, which ...
|
WO/2016/140245A1 |
The present invention addresses the problem of providing a curable composition whereby a cured material having a low Abbe number and increased durability can be fabricated, and of providing a curable composition in which increasing of th...
|
WO/2016/136425A1 |
Provided is a fluorine atom-containing polymer which is a condensation polymer of a fluorene derivative that provides a repeating unit represented by formula (1), a fluorene derivative that provides a repeating unit represented by formul...
|
WO/2016/129561A1 |
Provided is a method for efficiently and safely producing a compound having an N,N-bis(2-hydroxy-3-chloropropyl)amino group on an industrial scale. A compound having an N,N-bis(2-hydroxy-3-chloropropyl)amino group is produced by continuo...
|
WO/2016/123164A1 |
Disclosed are 2-phenyl-cyclopropylmethanamines which are selective 5-HT(2C) receptor agonists and are used in the treatments of diseases and conditions wherein modulation of 5-HT(2C) receptors provides a benefit, such as obesity and psyc...
|
WO/2016/117522A1 |
Provided is a charge-transporting varnish that includes: a charge-transporting material comprising an arylamine derivative represented by formula (1); a dopant; and an organic solvent.
|
WO/2016/105448A1 |
This disclosure provides compounds and compositions for use as analgesics and for the treatment of various conditions, such as pain, headaches, allodynia, and fibromyalgia. The disclosure also provides compounds that are ligands, and in ...
|
WO/2016/096905A1 |
This invention concerns the first mild and efficient synthesis of primary amines and amides from aldehydes or ketones using a heterogeneous metal catalystand amine donor. The initial heterogeneous metal- catalyzed reaction between the ca...
|
WO/2016/090859A1 |
The present invention relates to the field of copper-clad plates. Disclosed are a thermosetting resin composition for a degradable heat-conducting aluminum-based copper-clad plate, heat-conducting aluminum-based copper-clad plate, and pr...
|
WO/2016/089904A1 |
The present invention relates to the administration of compositions comprising trans-clomiphene or an analogue or salt thereof, for preventing and/or treating a filovirus disease in a subject.
|
WO/2016/078603A1 |
The synthesis of fluorescent molecules with aggregation-induced emission (AIE) characteristics and application as fluorescent probes for cellular imaging, killing, and antibiotic screening, wherein the cells are bacteria or mammalian cel...
|
WO/2016/078738A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
WO/2016/077548A1 |
Methods are provided for making rapid labeled dextran ladders and other calibrants useful in liquid chromatography. The methodologies include a two-step process comprising a reductive amination step of providing a reducing glycan and rea...
|
WO/2016/073277A1 |
A process for the preparation of 2-substituted-1,4-benzenediamines, a cosmetically acceptable salt thereof, or mixture thereof. The process according to the present invention is a particularly cost effective process in that it avoids sop...
|
WO/2016/073274A1 |
A telescoping process for the preparation of 2-methoxymethyl-p-phenylenediamine, a cosmetically acceptable salt thereof, or mixture thereof. The process according to the present invention is a particularly cost effective process in that ...
|
WO/2016/071249A1 |
The present invention relates to a novel method for producing substituted biphenylamines.
|
WO/2016/073276A1 |
A telescoping process for the preparation of 2-methoxymethyl-p-phenylenediamine, a cosmetically acceptable salt thereof, or mixture thereof. The process according to the present invention is a particularly cost effective process in that ...
|
WO/2016/066584A1 |
The present invention refers to new solid forms of Enclomiphene citrate and Enclomiphene base, processes for preparing thereof and uses.
|
WO/2016/054279A1 |
A method of preparing an intermediate of salmeterol (Compound 1, 2-amino-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl) ethanol) includes: reacting compound 2 with 2-methoxypropene in a first organic solvent to produce a reaction solution incl...
|
WO/2016/044918A1 |
The present invention provides processes for the preparation of a compound of Formula 2 or a salt thereof, wherein R1 is selected from the group consisting of H, C1-C3 alkyl, and C(0)R3; R3 is selected from the group consisting of C1-C6 ...
|
WO/2016/045983A1 |
This invention relates to polyetheramines based on 1,3-dialcohols, in particular to an etheramine mixture comprising at least 90% by weight, based on the total weight of the etheramine mixture, of an amine of Formula (I) and/or (II), whe...
|
WO/2016/038520A1 |
The present invention provides a process for the preparation of ticagrelor. The present invention further provides compounds of Formula IV, Formula V, Formula VI, Formula VIa, Formula VII, and Formula VIII, processes for their preparatio...
|
WO/2016/038112A1 |
The invention relates to a method for producing radiation-curable alkenyl ether polyols, to radiation-curable alkenyl ether polyols produced using the method according to the invention, and to the use thereof for the sysnthesis of radiat...
|
WO/2016/034327A1 |
Novel 2,2'-diamino biaryls of formula (I), (II) and (III), wherein R1-R10, R1'-R10', X1 - X3 and X1-X3' are defined in claim 1. The invention also relates to an electrochemical method for the production thereof.
|
WO/2016/034328A1 |
The invention relates to novel 2,2'-diamino biaryls of formula (I), (IIa), (IIb) and (III), wherein R1-R10, R1'-R10' and X1-X3 are defined in claim 1. The invention also relates to an electrochemical method for the production thereof.
|
WO/2016/030277A1 |
A compound of the general formula (I) in which R1, R2 and R3 are independently selected from C1- 4-alkyl and C1-4-hydroxyalkyl; each R4 is independently selected from hydrogen, C1-4-alkyl and C1-4-hydroxyalkyl; each R5 is independently s...
|
WO/2016/031961A1 |
The present invention provides an ionic liquid or plastic crystal comprising anions and cations, said anions including [C(SO2F)3]- and said cations including at least one type selected from the group consisting of 1-ethyl-3-methylimidazo...
|
WO/2016/028959A1 |
Disclosed are compounds of Formulas (I), (II), (III), (IV), and (V) and/or a salt thereof, wherein R1 is OH or OP(O)(OH)2, and X1, X2, X3, R2, R2a, Ra, Rb, and Rc are defined herein. Also disclosed are methods of using such compounds as ...
|
WO/2016/016641A1 |
A quaternary ammonium salt of formula wherein each of R1, R2, R3 and R4 is independently selected from an optionally substituted alkyl, alkenyl or aryl group having less than 8 carbon atoms and R5 is hydrogen or an optionally substituted...
|
WO/2016/007823A1 |
The invention provides methods for preparing substituted phenylalkanes. In particular, the processes comprise reacting a phenyl boronic compound with an α-β unsaturated carbonyl-containing compound via an asymmetric 1,4-addition reacti...
|
WO/2016/002762A1 |
The present invention provides a novel iridium compound, a method for producing this compound, a catalyst including this compound, and a method for producing a primary amine compound by reacting an alcohol compound and ammonia in the pre...
|
WO/2015/199167A1 |
Provided is a method for producing a substituted spiropyrido[1,2-a]pyrazine derivative, or a salt thereof, that are useful as anti-HIV agents. Also provided is a production intermediate. Compound [VIII] is obtained by reacting compound [...
|
WO/2015/190826A1 |
The present invention relates to an adhesive composition having anti-static properties, and a polarizing plate manufactured using same, and more specifically, to an adhesive composition having anti-static properties, and a polarizing pla...
|
WO/2015/178039A1 |
Provided is a rubber composition which can suppress coloration of the surface of a rubber article by having better weather resistance than conventional rubber compositions. This rubber composition is characterized by being formed by mixi...
|
WO/2015/166557A1 |
Provided is a method for producing a composition containing 3-chloro-4-methoxybenzylamine hydrochloride (CMBA-HCl) with high yield, wherein the purity of CMBA-HCl is high. The method comprises a chlorination step involving a chlorination...
|
WO/2015/159225A1 |
An organometallic complex of a tridentate bis(phosphine)-carbodicarbene ligand and a transition metal, is described. In some embodiments the ligand has the structure of Formula (I): The complexes are useful in methods of making an allyli...
|
WO/2015/151068A1 |
Novel synthetic analogues of 3-iodothyronamine of formula (I), pharmaceutical compositions containing the same, and medical uses thereof are described.
|
WO/2015/144497A1 |
The invention relates to etheramines of formula (I) or formula (II) or a mixture of etheramines of formula (I) and formula (II) based on 1,2-dialcohols, wherein R1 is a linear or branched alkyl group with 2 to 16 carbon atoms, R2 is a hy...
|
WO/2015/146912A1 |
Provided is the fluorene derivative represented in formula (1). (In the formula, R1 and/or R2 represents an alkoxy group, an alkenyloxy group, an alkynyloxy group, an aryloxy group, a heteroaryloxy group or an alkyl group that includes a...
|
WO/2015/144436A1 |
This invention relates to etheramines based on dialcohols, wherein the etheramines comprise at least three linear or branched C4-alkylene groupsand a process for the manufacture of these etheramines.
|
WO/2015/136596A1 |
Provided are: an alkylene oxide adduct manufacturing method capable of simultaneously achieving the ability to continuously manufacture an alkylene oxide adduct on a chosen scale from a small scale to a large scale, and the ability to co...
|
WO/2015/124290A1 |
The invention relates to novel compounds having fluoridated terminal groups, to the use thereof as surface-active substances, and to agents containing said compounds.
|
WO/2015/122502A1 |
The present invention pertains to a method for producing an optically active compound which includes a step for reducing an imino group of an imine compound or a step for reducing an unsaturated bond of a heterocyclic compound, while in ...
|
WO/2015/117846A1 |
The present invention relates to an amine of the formula (I) which is an adduct of 1,2-propylenediamine with an aryl monoglycidyl ether, to the use thereof as part of a hardener for epoxy resins, and to epoxy resin compositions obtained ...
|
WO/2014/118350A9 |
The invention relates to an aqueous coating composition comprising a compound having reactive groups A, and a quaternary ammonium compound according to Formula (I), (II) or (III), wherein R1 is an alkyl, alkenyl, alkylaryl or arylalkyl g...
|
WO/2015/098717A1 |
A nitro compound represented by formula (1) which is a raw material for producing a compound represented by formula (7) can be produced by reacting at least one type selected from the group consisting of a compound represented by formula...
|
WO/2015/090122A1 |
The present invention relates to a phenyl benzyl ether derivative and a preparation method and use thereof, and a part of the compound act as an A beta plaque imaging agent after being radioactively nuclide labelled, and the phenyl benzy...
|